Age Related Macular DegenerationNCT03326401
The Potential Role of Dietary Antioxidant Capacity on Age-Related Macular Degeneration
An observational study of Age Related Macular Degeneration, run by Hacettepe University at 1 site in Turkey (Türkiye).
Trial summary
Including eye health, nutrition plays a vital role for the sustainability of individuals health life. There is an increasing global concern about the issues related with eye health. Read more about this study
- Who is it for?
- Ages 50 years and older
- Conditions the study is for
- Age Related Macular Degeneration
- How many people
- 200 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jul 2015to 20 Feb 2016
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 years and older
- All sexes
- Adult, Older adult
Study population: 200 individuals voluntarily participated into the study including 100 patients diagnosed with AMD (50 women, 50 men) and 100 patients not diagnosed as AMD (50 women, 50 men) as control group.
Who may be able to join
- Subject older than 50 years old
- Clinical diagnosis of Age-Related Macular Degeneration Disease (Both Dry and Wet type)
Who cannot join
- Subject complying with a special diet
- History of cardiovascular disease
- History of eye surgery
- Subject younger than 50 years old
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Hacettepe University Hospital Department of Ophthalmology Polyclinic
Ankara, Altındağ, 06230
About this study
Official title: The Evaluation of Nutrition Status in Persons With Age-Related Macular Degeneration
Including eye health, nutrition plays a vital role for the sustainability of individuals health life. There is an increasing global concern about the issues related with eye health. In 2010, in order to take attention to these issues, World Health Organization (WHO) defined the main reasons of vision disorders as refraction defects of eye diseases (43 %), cataract (33 %), glaucoma (2 %), age-related macular degeneration (AMD) (1 %), diabetic retinopathy (1 %) and undetermined natural reasons (18 %). This report also stated the three biggest reasons of blindness as cataract (51 %), glaucoma (8 %) and AMD (5 %).
AMD is a multi-factorial disease in which the genetic predisposition plays important role with environmental factors and metabolic conditions, except for age. Especially cigarette is the secondary important risk factor for dry-type AMD. In the Age Related Eye Disease Study (AREDS), it was stated that AMD prevalence is higher in white races, compared with races which are not white. At the same time, AREDS searched the effect of diet supplements on the progression of AMD disease. In terms of the patients followed for six years, it was reported that the formulation C and E vitamins, beta carotene and zinc decreased the progression risk of AMD from middle levels to advanced levels by 34 %. In AREDS-2 study completed in 2012, it was shown that the extraction of beta carotene from the formulation and the decrease of zinc did not affect the progression rate of the disease. In the group using beta carotene, including persons who were used to smoke but gave up at least one year ago, the rate of becoming lung cancer was observed as substantially high. Moreover, the use of lutein and zeaxanthin instead of beta carotene in the formula did not increase the risk of lung cancer. In addition, it was shown that omega-3 fatty acids did not decrease risk progression.
Read more
In current data, the effect of the intake of carotenoid and antioxidant increased with diet on AMD is not coherent. Likewise, the epidemiological evidences about the relation between diet fat intake and AMD are contradictory. The consumption of fatty fish is related with increased poly-unsaturated fatty acid intake and decreases the risk of AMD. However, it was reported the high rate of total fat intake in other studies as risk factor for AMD. In another study, there was not any important relation found between diet fat intake and AMD occurrence after the correction of other variables. In the interventional AREDS-2 study, it was reported that the additional intake of long-chain omega-3 poly-unsaturated fatty acids did not have any beneficial effect.
The pathophysiological mechanism responsible from the possible relation between obesity and AMD is not clearly known. There are various hypotheses about how obesity causes AMD. In the first hypothesis, obesity can cause AMD after obesity increases systematic oxidative stress. In the second hypothesis, obesity can play a role in AMD pathophysiology as the cause of hyperleptinemia. The studies also prescribed that inflammation could play a role in the progression of AMD and also showed that plasma fibrinogen and other inflammation indicators could be related with late AMD. In Pathologies Oculaires Liées à l'Age (POLA) study made with the participation of many Europeans, it was observed that the progression of late AMD increased by two times in obese individuals and in early AMD, obesity did not affect the progression of disease. In the treatment of this disease which have age-related progression, proper nutrition, vitamin/mineral/supplement usage and the development of precautionary strategies play an important role.
When compared with Body Mass Index (BMI), it was found that the measure of abdominal obesity (waist/hip rate and waist circumference) was the better determinant of chronic diseases such as diabetics and cardiovascular disease. Some evidences in the United States of America indicated that the relation between waist/hip rate and AMD gave stronger results when compared with the relation between BMI and AMD. For middle age cohort, after six years of follow-up, a group of researchers reported that the decrease of waist/hip rate also decreased the risk of AMD and the results were the same for waist circumference, even if the evidences were weak. In another study, it was reported that the increase of waist/hip rate or waist circumference also increased the progression of AMD.
This study was planned with the aim of determining the occurrence of AMD by evaluating dietary total antioxidant capacity, diet components and some anthropometric measures of individuals having age related macular degeneration (AMD). In the study, the possible effect of nutrition on the occurrence of disease was evaluated by comparing healthy individuals with dietary total antioxidant capacity and some anthropometric measures of individuals with AMD.
Read the detailed description
While being benefited from the results of previous studies, the sample size of the research was type 1 error performance α=0.05 and type 2 error performance β=0.20. The power of the test was taken as 1-β=0.80 and the power analysis was statistically made with NCCS PAS 11 program. 200 individuals voluntarily participated into the study as control group, including 100 patients diagnosed with AMD (50 women, 50 men) and 100 patients not diagnosed as AMD (50 women, 50 men).
Sociodemographic Variables The questionnaire form, prepared to determine socio-demographic features of individuals participating in the research, was applied by the research with the method of face-to-face interview. The socio-demographic features of individuals (gender, age, occupation, educational status, health conditions), use of cigarettes and drugs was questioned.
Anthropometric Variables The body weight of the individuals were measured with a calibrated electronic scale, which could measure even 0.1 kg, while the individuals were hungry, in light clothes and their shoes were taken off. The body lengths were measured by the researcher with the tape measure while they were standing upright in Frankfurt plane position (ear canal and lower margin of orbit in the same horizontal plane, facing forward). BMI was calculated with the formula [body weight (kg)/body length (m2)]. BMI evaluation was made while the classification developed by World Health Organization (WHO) was taken as a basis (13). According to this classification; (BMI<18.5 kg/m2 thin, 18.5< 24.9 kg/m2 normal, 25.0-29.9 kg/m2 overweight and ≥30 kg/m2 obese. The waist circumference of the individuals was measured with tape measure by founding the midpoint between the lowest rib and umbilicus. The relation between waist circumference and chronic diseases is as follows: If the waist circumference is ≥88 cm for women and ≥102 cm for men, it is shown as high risk. The hip circumference of the individuals was measured with a tape measure from the highest point by standing the left side of the individuals. If the waist/hip rate is over 0.85 for women and over 0.90 for men, the risk of chronic diseases increases.
Assesment of dietary intake and diet total antioxidant capacity Participants' dietary intake was assessed using food frequency questionnaire (FFQ). The FFQ included 65 food items traditionally consumed in Turkey. Foods were classified into the following food categories: milk and dairy products, meat and meat products, fruits, vegetables, breads and cereals, beverages, and desserts. Intake frequencies for the food items consisted of eight categories ranging from never/once a month to more than one per day. Trained interviewers asked participants how often they had consumed one portion of each food item in generally. To compute the total amount of food intake per day, the reported frequency of consumption for each food item was multiplied by the portion size and then total food intake was converted to nutrient intake based on the food's nutrient profile. Standardized food recipes for Turkey and Nutrition Information System (BEBIS) program which is a food composition database for nutrient estimation were used to determine average daily energy and nutrient intake for each participant. These values were compared with the recommended daily allowance values to determine the energy and nutrient requirement meeting status and the requirement meeting percentages were calculated.
By using food intake frequency amounts, dietary total antioxidant capacity was tried to be determined approximately with the use of data obtained from a large-scale study made by Carlsen for developing a database including total antioxidant component of essential nutrients. The antioxidant amount in 100 g food given for each nutrient group in the related resource was used as standard antioxidant activity value in this study and the approximate antioxidant activity values of the grouped food intake amounts of individuals were calculated.
Statistical Analysis In the statistical evaluation of data obtained from the study, Statistical Package for Social Science (SPSS) 22.0 program was used. For the data obtained from the measures of individuals participating in the study, average, standard deviation and the lowest and the highest values were calculated. The distribution of data determined with numbers was given with number-percentage tables. While evaluating constant data, it was determined with Kolmogorov Smirnov test whether there was normal distribution or not. The data of individuals having normal distribution were analyzed with parametric statistical tests and the data of individuals not having normal distribution were analyzed with non-parametric statistical tests. Odds ratios (OR) and 95% confidence intervals (CI) were calculated by univariate logistic regression analysis separately for food group, BMI, and adjusted age, gender before combined in multivariate logistic regression. Logistic regression analysis was performed to determine risk factors for AMD using odds ratio estimates with 95% confidence intervals. Furthermore, a stepwise multivariate regression analysis was performed, with p value less than 0.05 being required for entering the model and remaining there.
- Conditions
- Age Related Macular Degeneration
- Keywords
- dietary total antioxidant activity, nutritional status, macular degeneration, glycemic load, glycemic index, nutrient intake
- Medical subject headings
- Macular Degeneration
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Case (AMD group) | Case group including 100 patients diagnosed with age-related macular degeneration (50 women, 50 men).Demographic data and dietary intake of different food groups were assessed by a standardized interviewer-assisted questionaire with the method of face-to-face interview. The body weight of the individuals were measured with a calibrated electronic scale,anthropometric measurements were measured by the researcher. Participants' dietary intake was assessed using food frequency questionaire (FFQ). The FFQ included 65 food items traditionally consumed in Turkey. Foods were classified into the following food categories: milk and dairy products, meat and meat products, fruits, vegetables, breads and cereals, beverages, and desserts. | |
| Control (Non-AMD group) | Case group including 100 patients not diagnosed with age-related macular degeneration (50 women, 50 men).Demographic data and dietary intake of different food groups were assessed by a standardized interviewer-assisted questionaire with the method of face-to-face interview. The questionaire form, prepared to determine socio-demographic features of individuals participating in the research, was applied by the research with the method of face-to-face interview. The body weight of the individuals were measured with a calibrated electronic scale,anthropometric measurements were measured by the researcher. Participants' dietary intake was assessed using food frequency questionaire (FFQ). The FFQ included 65 food items traditionally consumed in Turkey. Foods were classified into the following food categories: milk and dairy products, meat and meat products, fruits, vegetables, breads and cereals, beverages, and desserts. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Body Mass Index (BMI)
It will calculate by researcher with BMI formula: kg/m^2
Measured: up to 20 weeks
Dietary total antioxidant capacity of participants
3 day food record of participants will be taken and evaluated by researcher. Nutrition information System (BeBİS) software will be used for calculate daily consumption of nutrients.
Measured: up to 20 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Oct 2017
- Study start1 Jul 2015
- Primary completion1 Oct 2015
- Study completion20 Feb 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (7)Papers the sponsor has linked to this study.
- Other trials for Age Related Macular DegenerationStudies of the same condition, open and under way.
- More trials run by Hacettepe UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Retrospective
- Enrolment
- 200 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hacettepe University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, F. Gülhan Samur, Hacettepe University
- Investigators
- F.Gülhan Samur, Ass. Prof., Principal investigator, Hacettepe UniversitySibel Kadayıfçılar, Prof., Study chair, Hacettepe UniversitySedat Arslan, RA, Study chair, Hacettepe University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03326401
- Sponsor's protocol ID
- GO 15/628
- Status last verified
- Oct 2017
- First submitted
- 19 Oct 2017
- Last updated
- 1 Nov 2017
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: Study protocol will be shared with other researches in one year.
Publications
Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant age-related maculopathy in men. Arch Ophthalmol. 2001 Sep;119(9):1259-65. doi: 10.1001/archopht.119.9.1259.
PubMed 11545630Klein BE, Klein R, Lee KE, Jensen SC. Measures of obesity and age-related eye diseases. Ophthalmic Epidemiol. 2001 Sep;8(4):251-62. doi: 10.1076/opep.8.4.251.1612.
PubMed 11471093Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd; Age-Related Eye Disease Study Research Group. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology. 2005 Apr;112(4):533-9. doi: 10.1016/j.ophtha.2004.10.047.
PubMed 15808240Defay R, Delcourt C, Ranvier M, Lacroux A, Papoz L. Relationships between physical activity, obesity and diabetes mellitus in a French elderly population: the POLA study. Pathologies Oculaires liees a l' Age. Int J Obes Relat Metab Disord. 2001 Apr;25(4):512-8. doi: 10.1038/sj.ijo.0801570.
PubMed 11319655Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, Hofman A, Jensen S, Wang JJ, de Jong PT. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology. 2001 Apr;108(4):697-704. doi: 10.1016/s0161-6420(00)00580-7.
PubMed 11297486Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol. 2003 Jun;121(6):785-92. doi: 10.1001/archopht.121.6.785.
PubMed 12796248Cho E, Seddon JM, Rosner B, Willett WC, Hankinson SE. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol. 2004 Jun;122(6):883-92. doi: 10.1001/archopht.122.6.883.
PubMed 15197064
Study at a glance
From the registry record, last updated by the sponsor on 1 Nov 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Evaluation of Nutrition Status in Persons With Age-Related Macular Degeneration
- ClinicalTrials.gov ID
- NCT03326401
- Acronym / sponsor ID
- GO 15/628
- Conditions
- Age Related Macular Degeneration
- Keywords
- dietary total antioxidant activity, nutritional status, macular degeneration, glycemic load, glycemic index, nutrient intake
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 200 participants (actual)
- Lead sponsor
- Hacettepe UniversityUniversity, hospital or other
- Study start
- 1 Jul 2015 (actual)
- Primary completion
- 1 Oct 2015 (actual)
- Study completion
- 20 Feb 2016 (actual)
- First posted
- 31 Oct 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Including eye health, nutrition plays a vital role for the sustainability of individuals health life. There is an increasing global concern about the issues related with eye health. In 2010, in order to take attention to these issues, World Health Organization (WHO) defined the main reasons of vision disorders as refraction defects of eye diseases (43 %), cataract (33 %), glaucoma (2 %), age-related macular degeneration (AMD) (1 %), diabetic retinopathy (1 %) and undetermined natural reasons (18 %). This report also stated the three biggest reasons of blindness as cataract (51 %), glaucoma (8 %) and AMD (5 %).
AMD is a multi-factorial disease in which the genetic predisposition plays important role with environmental factors and metabolic conditions, except for age. Especially cigarette is the secondary important risk factor for dry-type AMD. In the Age Related Eye Disease Study (AREDS), it was stated that AMD prevalence is higher in white races, compared with races which are not white. At the same time, AREDS searched the effect of diet supplements on the progression of AMD disease. In terms of the patients followed for six years, it was reported that the formulation C and E vitamins, beta carotene and zinc decreased the progression risk of AMD from middle levels to advanced levels by 34 %. In AREDS-2 study completed in 2012, it was shown that the extraction of beta carotene from the formulation and the decrease of zinc did not affect the progression rate of the disease. In the group using beta carotene, including persons who were used to smoke but gave up at least one year ago, the rate of becoming lung cancer was observed as substantially high. Moreover, the use of lutein and zeaxanthin instead of beta carotene in the formula did not increase the risk of lung cancer. In addition, it was shown that omega-3 fatty acids did not decrease risk progression.
In current data, the effect of the intake of carotenoid and antioxidant increased with diet on AMD is not coherent. Likewise, the epidemiological evidences about the relation between diet fat intake and AMD are contradictory. The consumption of fatty fish is related with increased poly-unsaturated fatty acid intake and decreases the risk of AMD. However, it was reported the high rate of total fat intake in other studies as risk factor for AMD. In another study, there was not any important relation found between diet fat intake and AMD occurrence after the correction of other variables. In the interventional AREDS-2 study, it was reported that the additional intake of long-chain omega-3 poly-unsaturated fatty acids did not have any beneficial effect.
The pathophysiological mechanism responsible from the possible relation between obesity and AMD is not clearly known. There are various hypotheses about how obesity causes AMD. In the first hypothesis, obesity can cause AMD after obesity increases systematic oxidative stress. In the second hypothesis, obesity can play a role in AMD pathophysiology as the cause of hyperleptinemia. The studies also prescribed that inflammation could play a role in the progression of AMD and also showed that plasma fibrinogen and other inflammation indicators could be related with late AMD. In Pathologies Oculaires Liées à l'Age (POLA) study made with the participation of many Europeans, it was observed that the progression of late AMD increased by two times in obese individuals and in early AMD, obesity did not affect the progression of disease. In the treatment of this disease which have age-related progression, proper nutrition, vitamin/mineral/supplement usage and the development of precautionary strategies play an important role.
When compared with Body Mass Index (BMI), it was found that the measure of abdominal obesity (waist/hip rate and waist circumference) was the better determinant of chronic diseases such as diabetics and cardiovascular disease. Some evidences in the United States of America indicated that the relation between waist/hip rate and AMD gave stronger results when compared with the relation between BMI and AMD. For middle age cohort, after six years of follow-up, a group of researchers reported that the decrease of waist/hip rate also decreased the risk of AMD and the results were the same for waist circumference, even if the evidences were weak. In another study, it was reported that the increase of waist/hip rate or waist circumference also increased the progression of AMD.
This study was planned with the aim of determining the occurrence of AMD by evaluating dietary total antioxidant capacity, diet components and some anthropometric measures of individuals having age related macular degeneration (AMD). In the study, the possible effect of nutrition on the occurrence of disease was evaluated by comparing healthy individuals with dietary total antioxidant capacity and some anthropometric measures of individuals with AMD.
Detailed description
While being benefited from the results of previous studies, the sample size of the research was type 1 error performance α=0.05 and type 2 error performance β=0.20. The power of the test was taken as 1-β=0.80 and the power analysis was statistically made with NCCS PAS 11 program. 200 individuals voluntarily participated into the study as control group, including 100 patients diagnosed with AMD (50 women, 50 men) and 100 patients not diagnosed as AMD (50 women, 50 men).
Sociodemographic Variables The questionnaire form, prepared to determine socio-demographic features of individuals participating in the research, was applied by the research with the method of face-to-face interview. The socio-demographic features of individuals (gender, age, occupation, educational status, health conditions), use of cigarettes and drugs was questioned.
Anthropometric Variables The body weight of the individuals were measured with a calibrated electronic scale, which could measure even 0.1 kg, while the individuals were hungry, in light clothes and their shoes were taken off. The body lengths were measured by the researcher with the tape measure while they were standing upright in Frankfurt plane position (ear canal and lower margin of orbit in the same horizontal plane, facing forward). BMI was calculated with the formula [body weight (kg)/body length (m2)]. BMI evaluation was made while the classification developed by World Health Organization (WHO) was taken as a basis (13). According to this classification; (BMI<18.5 kg/m2 thin, 18.5< 24.9 kg/m2 normal, 25.0-29.9 kg/m2 overweight and ≥30 kg/m2 obese. The waist circumference of the individuals was measured with tape measure by founding the midpoint between the lowest rib and umbilicus. The relation between waist circumference and chronic diseases is as follows: If the waist circumference is ≥88 cm for women and ≥102 cm for men, it is shown as high risk. The hip circumference of the individuals was measured with a tape measure from the highest point by standing the left side of the individuals. If the waist/hip rate is over 0.85 for women and over 0.90 for men, the risk of chronic diseases increases.
Assesment of dietary intake and diet total antioxidant capacity Participants' dietary intake was assessed using food frequency questionnaire (FFQ). The FFQ included 65 food items traditionally consumed in Turkey. Foods were classified into the following food categories: milk and dairy products, meat and meat products, fruits, vegetables, breads and cereals, beverages, and desserts. Intake frequencies for the food items consisted of eight categories ranging from never/once a month to more than one per day. Trained interviewers asked participants how often they had consumed one portion of each food item in generally. To compute the total amount of food intake per day, the reported frequency of consumption for each food item was multiplied by the portion size and then total food intake was converted to nutrient intake based on the food's nutrient profile. Standardized food recipes for Turkey and Nutrition Information System (BEBIS) program which is a food composition database for nutrient estimation were used to determine average daily energy and nutrient intake for each participant. These values were compared with the recommended daily allowance values to determine the energy and nutrient requirement meeting status and the requirement meeting percentages were calculated.
By using food intake frequency amounts, dietary total antioxidant capacity was tried to be determined approximately with the use of data obtained from a large-scale study made by Carlsen for developing a database including total antioxidant component of essential nutrients. The antioxidant amount in 100 g food given for each nutrient group in the related resource was used as standard antioxidant activity value in this study and the approximate antioxidant activity values of the grouped food intake amounts of individuals were calculated.
Statistical Analysis In the statistical evaluation of data obtained from the study, Statistical Package for Social Science (SPSS) 22.0 program was used. For the data obtained from the measures of individuals participating in the study, average, standard deviation and the lowest and the highest values were calculated. The distribution of data determined with numbers was given with number-percentage tables. While evaluating constant data, it was determined with Kolmogorov Smirnov test whether there was normal distribution or not. The data of individuals having normal distribution were analyzed with parametric statistical tests and the data of individuals not having normal distribution were analyzed with non-parametric statistical tests. Odds ratios (OR) and 95% confidence intervals (CI) were calculated by univariate logistic regression analysis separately for food group, BMI, and adjusted age, gender before combined in multivariate logistic regression. Logistic regression analysis was performed to determine risk factors for AMD using odds ratio estimates with 95% confidence intervals. Furthermore, a stepwise multivariate regression analysis was performed, with p value less than 0.05 being required for entering the model and remaining there.
Study design
- Observational model
- Case-control
- Time perspective
- Retrospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Case (AMD group) | – | –Case group including 100 patients diagnosed with age-related macular degeneration (50 women, 50 men).Demographic data and dietary intake of different food groups were assessed by a standardized interviewer-assisted questionaire with the method of face-to-face interview. The body weight of the individuals were measured with a calibrated electronic scale,anthropometric measurements were measured by the researcher. Participants' dietary intake was assessed using food frequency questionaire (FFQ). The FFQ included 65 food items traditionally consumed in Turkey. Foods were classified into the following food categories: milk and dairy products, meat and meat products, fruits, vegetables, breads and cereals, beverages, and desserts. |
| Control (Non-AMD group) | – | –Case group including 100 patients not diagnosed with age-related macular degeneration (50 women, 50 men).Demographic data and dietary intake of different food groups were assessed by a standardized interviewer-assisted questionaire with the method of face-to-face interview. The questionaire form, prepared to determine socio-demographic features of individuals participating in the research, was applied by the research with the method of face-to-face interview. The body weight of the individuals were measured with a calibrated electronic scale,anthropometric measurements were measured by the researcher. Participants' dietary intake was assessed using food frequency questionaire (FFQ). The FFQ included 65 food items traditionally consumed in Turkey. Foods were classified into the following food categories: milk and dairy products, meat and meat products, fruits, vegetables, breads and cereals, beverages, and desserts. |
Who may qualify
- Ages
- 50 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- 200 individuals voluntarily participated into the study including 100 patients diagnosed with AMD (50 women, 50 men) and 100 patients not diagnosed as AMD (50 women, 50 men) as control group.
Key inclusion criteria (2 listed)
- Subject older than 50 years old
- Clinical diagnosis of Age-Related Macular Degeneration Disease (Both Dry and Wet type)
Key exclusion criteria (4 listed)
- Subject complying with a special diet
- History of cardiovascular disease
- History of eye surgery
- Subject younger than 50 years old
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Body Mass Index (BMI)
Time frame: up to 20 weeks
It will calculate by researcher with BMI formula: kg/m^2
Dietary total antioxidant capacity of participants
Time frame: up to 20 weeks
3 day food record of participants will be taken and evaluated by researcher. Nutrition information System (BeBİS) software will be used for calculate daily consumption of nutrients.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Nov 2017.
- Results publication: PubMed 11545630Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant age-related maculopathy in men. Arch Ophthalmol. 2001 Sep;119(9):1259-65. doi: 10.1001/archopht.119.9.1259.
- Results publication: PubMed 11471093Klein BE, Klein R, Lee KE, Jensen SC. Measures of obesity and age-related eye diseases. Ophthalmic Epidemiol. 2001 Sep;8(4):251-62. doi: 10.1076/opep.8.4.251.1612.
- Results publication: PubMed 15808240Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd; Age-Related Eye Disease Study Research Group. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology. 2005 Apr;112(4):533-9. doi: 10.1016/j.ophtha.2004.10.047.
- Results publication: PubMed 11319655Defay R, Delcourt C, Ranvier M, Lacroux A, Papoz L. Relationships between physical activity, obesity and diabetes mellitus in a French elderly population: the POLA study. Pathologies Oculaires liees a l' Age. Int J Obes Relat Metab Disord. 2001 Apr;25(4):512-8. doi: 10.1038/sj.ijo.0801570.
- Results publication: PubMed 11297486Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, Hofman A, Jensen S, Wang JJ, de Jong PT. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology. 2001 Apr;108(4):697-704. doi: 10.1016/s0161-6420(00)00580-7.
- Results publication: PubMed 12796248Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol. 2003 Jun;121(6):785-92. doi: 10.1001/archopht.121.6.785.
- Results publication: PubMed 15197064Cho E, Seddon JM, Rosner B, Willett WC, Hankinson SE. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol. 2004 Jun;122(6):883-92. doi: 10.1001/archopht.122.6.883.
- who bmi classificationLink provided by the sponsor.
- nutrition information systemLink provided by the sponsor.
- Individual participant dataSharing planned: Undecided. Study protocol will be shared with other researches in one year.
Related trials for Age Related Macular Degeneration
RecruitingPhase 3
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Neovascular Age-related Macular Degeneration
RecruitingObservational study
Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
Age-related Macular Degeneration (AMD)
Active, not recruitingObservational study
Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)
Diabetic Macular Edema, Neovascular Age-related Macular Degeneration
Active, not recruitingObservational study
Retinal Pigment Epithelium Safety Study For Patients In B4711001
Age Related Macular Degeneration
RecruitingObservational study
National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases
Inherited Ophthalmic Diseases, Hypopigmentation Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
F.Gülhan Samur, Ass. Prof. principal investigator
Hacettepe University
Sibel Kadayıfçılar, Prof. study chair
Hacettepe University
Sedat Arslan, RA study chair
Hacettepe University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Age Related Macular Degeneration, run by Hacettepe University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Nov 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Body Mass Index (BMI) (time frame: up to 20 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03326401, which also lists 7 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Nov 2017.